Irexime (Clindamycin, Anhydrous Benzoyl Peroxide)

Clindamycin, one of the active ingredients in Irexime, inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit of Cutibacterium acnes. This action reduces bacterial proliferation and the associated inflammatory response that contributes to acne development.

The dosage regimen for Irexime is determined by the prescribing clinician based on the severity of acne, patient age, and skin tolerance. Typically, a thin layer is applied once or twice daily to clean, dry skin, but the exact frequency and duration should follow the prescriber’s instructions.

Safety data for Irexime in pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks and benefits with their healthcare provider before initiating therapy.

To order Irexime, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Irexime combines an antibiotic (clindamycin) with a keratolytic (benzoyl peroxide), offering both antibacterial and comedolytic actions in a single formulation. Compared with monotherapy agents, this dual mechanism can improve efficacy and reduce the risk of bacterial resistance, making it a preferred option for moderate acne.

Irexime should be stored at room temperature, below 25 °C, in its original packaging. Keep the container tightly closed, protect it from moisture and direct sunlight, and avoid freezing to maintain product stability.

Apply a thin layer of Irexime to the affected areas of the skin once or twice daily, as directed by a healthcare professional. The skin should be clean and dry before application, and hands should be washed after use to prevent accidental contact with eyes or mucous membranes.

Serious risks, though rare, include severe allergic reactions such as anaphylaxis, Stevens‑Johnson syndrome, and angioedema. Patients should seek immediate medical attention if they experience swelling of the face, lips, tongue, difficulty breathing, or widespread skin blistering.

Irexime should be avoided in individuals with known hypersensitivity to clindamycin, benzoyl peroxide, or any component of the formulation. It is also contraindicated on severely damaged or infected skin, and caution is advised for patients with a history of severe allergic reactions.